Evidence for Aldosterone Antagonism in Heart Failure
Activation of the renin–angiotensin–aldosterone system is the ultimate pathophysiological hallmark in heart failure. Though aldosterone primarily appears to regulate electrolyte homeostasis by acting on distal nephrons in the kidneys, its effects are far-reaching across the cardiovascular system as...
Saved in:
| Main Authors: | Rishi Sethi, Pravesh Vishwakarma, Akshyaya Pradhan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2024-11-01
|
| Series: | Cardiac Failure Review |
| Online Access: | https://www.cfrjournal.com/articleindex/cfr.2024.10 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deferred Stenting for Heavy Thrombus Burden During Percutaneous Coronary Intervention for ST-Elevation MI
by: Akshyaya Pradhan, et al.
Published: (2021-03-01) -
Clinical and Radiological Presentations of Various Pulmonary Infections in Hospitalized Diabetes Mellitus Patients: A Prospective, Hospital-Based, Comparative, Case Series Study
by: Pravesh Vishwakarma, et al.
Published: (2021-01-01) -
Ezetimibe and Improving Cardiovascular Outcomes: Current Evidence and Perspectives
by: Akshyaya Pradhan, et al.
Published: (2020-01-01) -
Oxidative Stress, Antioxidant Capacity, and Inflammatory Markers in Patients with Idiopathic Complete Heart Block
by: Shobhit Shah, et al.
Published: (2024-07-01) -
Finerenone: a breakthrough mineralocorticoid receptor antagonist for heart failure, diabetes and chronic kidney disease
by: Akshyaya Pradhan, et al.
Published: (2024-12-01)